Results
eNauka >
Results >
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
| Title: | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial | Authors  : | Ray, Kausik K.; ...; Ristić, Arsen D.   ; ...; (broj koautora 24) |
Issue Date: | 2019 | Publication: | The lancet. Diabetes & endocrinology | ISSN: | 2213-8587 Lancet Diabetes & Endocrinology Search Idenfier |
Publisher: | London : The Lancet, Diabetes & Endocrinology | Type: | Article | Collation: | vol. 7 br. 8 str. 618-628 | DOI: | 10.1016/S2213-8587(19)30158-5 | WoS-ID: | 000475553300016 | Scopus-ID: | 2-s2.0-85068931122 | PMID: | 31272931 | URI: | https://enauka.gov.rs/handle/123456789/818042 | URL: | https://www.thelancet.com/journals/landia/article/PIIS2213-8587(19)30158-5/abstract | Project: | Sanofi Regeneron Pharmaceuticals |
Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.